Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 205 | 200 | 205 | 203 | 0 |
| Accounts receivable | -152 | -170 | 595 | 65 | 31 |
| Other Working Capital | 105 | -45 | 743 | -291 | 343 |
| Other Operating Activity | -1,523 | -896 | -1,815 | -1,145 | -356 |
| Operating Cash Flow | $-1,366 | $-911 | $-271 | $-1,168 | $19 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -5 | -16 | N/A | N/A |
| Net Acquisitions | N/A | 20 | -12 | N/A | N/A |
| Sale Of Investment | N/A | -489 | N/A | N/A | N/A |
| Other Investing Activity | -2 | 0 | 587 | 0 | 0 |
| Investing Cash Flow | $-11 | $-474 | $559 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -3 | -5 | N/A | N/A |
| Common Stock Issued | 863 | 29,377 | 51 | -86 | 2,618 |
| Other Financing Activity | -22 | -46 | 139 | 21 | 0 |
| Financing Cash Flow | $841 | $29,328 | $184 | $-66 | $2,618 |
| Beginning Cash Position | 29,362 | 2,580 | 2,083 | 3,988 | 1,351 |
| End Cash Position | 28,827 | 30,482 | 2,580 | 2,083 | 3,988 |
| Net Cash Flow | $-536 | $27,943 | $471 | $-1,860 | $2,637 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,366 | -911 | -271 | -1,168 | 19 |
| Capital Expenditure | -9 | -5 | -16 | N/A | N/A |
| Free Cash Flow | -1,375 | -916 | -287 | -1,168 | 19 |